CD44 and breast carcinoma: In vitro studies have shown that CD44 overexpression is associated with invasiveness; nevertheless, CD44 null mutation has been linked to a protective effect against breast carcinoma.[16] Therefore, the role of CD44 is unclear, yielding contradictory results.